BiotechTube
Home/Pipeline/Broad Generic Portfolio Expansion

Broad Generic Portfolio Expansion

Various

Bioequivalence/RegistrationActive

Key Facts

Indication
Various
Phase
Bioequivalence/Registration
Status
Active
Company
JSC Pharmstandard

About JSC Pharmstandard

Founded in 2003, JSC Pharmstandard has solidified its position as Russia's leading pharmaceutical manufacturer, driven by a mission to ensure the availability of affordable, high-quality medicines. Its strategy is built on massive-scale generic drug production, a broad portfolio covering over 30 dosage forms, and active support of national healthcare priorities, including import substitution. Recent partnerships with academic institutions and innovation camps underscore its focus on technological modernization within the generics and biosimilars space to maintain market leadership.

View full company profile

Therapeutic Areas

Broad GenericsCardiovascularCNSAnti-infectivesConsumer Health

Other Various Drugs

DrugCompanyPhase
New Generic ApprovalsChina SXT PharmaceuticalsApplication Submitted / BE Stage
New Dosage Form DevelopmentUniverse PharmaceuticalsDevelopment
New TCM Formula RegistrationUniverse PharmaceuticalsDevelopment
Bag APIsChemWerthApproved
Oral APIsChemWerthApproved
Companion Diagnostics DevelopmentKiffik BiomedicalPre-clinical
Portfolio of Complex Generics & 505(b)(2) ProductsAlvogenApproved/Commercial
Portfolio of 40+ productsPraxgen PharmaceuticalsDevelopment
Drug Repositioning ServiceBiovistaService
Custom Control DevelopmentAnchor MolecularDevelopment/Commercial
Portfolio from Steriscience PartnershipArmas PharmaceuticalsANDA Development/Filing
Generic Medicinal Products DevelopmentBasic PharmaCommercial